Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients
Clinical trial NCT04126967 · UNKNOWN
Trial details
- NCT number
- NCT04126967
- Sponsor
- Xianmin Song, MD
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2022-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.